Merrimack Pharmaceuticals' Series D Round

Merrimack Pharmaceuticals raised a round of funding on April 08, 2005.

Merrimack Pharmaceuticals (NASDAQ: MACK) is a biopharmaceutical company discovering, developing, and commercializing medicines paired with companion diagnostics for the treatment of serious diseases, …

Articles about Merrimack Pharmaceuticals' Series D Round: